Innovative approaches to cervical cancer care in Mozambique
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
This study is testing new ways to provide cervical cancer screening and treatment along with family planning services in Mozambique to see how well they work and if people like them.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 14600 (estimated) |
| Ages | 30 Years to 49 Years |
| Sex | Female |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT05359016 on ClinicalTrials.gov |
What this trial studies
This operational research focuses on developing and testing integrated service delivery models for cervical cancer screening and treatment (CCS&PT) alongside voluntary family planning (FP) services in Gaza and Maputo Cidade Provinces in Mozambique. The study aims to evaluate the health impact of these integrated services, identify effective promotional strategies, and assess the cost and acceptability of the services among clients and providers. By utilizing HPV testing for cervical cancer screening, the study seeks to optimize the uptake of both CCS&PT and FP services.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 30 to 49 years or all women living with HIV who are not currently pregnant and reside in Maputo or Gaza.
Not a fit: Patients who have undergone a total hysterectomy or those with physical or mental impairments that inhibit participation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve cervical cancer screening and treatment uptake, leading to better health outcomes for women in Mozambique.
How similar studies have performed: While integrated service delivery models have been explored in various contexts, this specific approach in Mozambique is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women 30 - 49 years or all women living with HIV * Not currently pregnant * Patients with a cervix (women who have undergone a total hysterectomy with removal of the cervix are not eligible) * Living in Maputo or Gaza * Willing and able to provide informed consent for services. Exclusion Criteria: * Not meeting the inclusion criteria * Physical or mental impairment that inhibits participation in the study * Pregnant women
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Kathleen Schmeler, MD — M.D. Anderson Cancer Center
- Study coordinator: Mila Salecedo, MD, PHD
- Email: mpsalcedo@mdanderson.org
- Phone: 832-696-6794
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.